Results of a european randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas

This publication has 10 references indexed in Scilit:

• A note on quantifying follow-up in studies of failure time
  Controlled Clinical Trials, 1996
• An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Tumor Oxygenation: A New Predictive Parameter in Locally Advanced Cancer of the Uterine Cervix
  Gynecologic Oncology, 1993
• Oxygenation of head and neck tumors
  Cancer, 1993
• First analysis on tumor regression for the European randomized trial of etanidazole combined with radiotherapy in head and neck carcinomas
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85
  Radiotherapy and Oncology, 1991
• Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1988
• Minimization: A new method of assigning patients to treatment and control groups
  Clinical Pharmacology & Therapeutics, 1974